Status:
COMPLETED
Addressing Personalized Needs in Clostridioides Difficile Infection
Lead Sponsor:
Hellenic Institute for the Study of Sepsis
Conditions:
Clostridioides Difficile Infection
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
BEYOND is aiming to demonstrate how by enrichment of the available SPECIFY score, patients at great likelihood for CDI with unfavorable outcome are early detected
Detailed Description
In a previous project, following GWAS analysis of the DNA and measurement of serum biomarkers coming from 134 patients a prediction score named SPECIFY was developed. The SPECIFY score comprises four ...
Eligibility Criteria
Inclusion
- Age more than or equal to 18 years
- Both genders
- Diarrhea defined as at least 3 episodes of unformed stools in the last 24hours according to the Bristol stool chart
- Presence of C.difficile in stool. This is defined as any stool sample positive for the presence of glutamate dehydrogenase (GDH) and for the presence of toxin A and/or B.
Exclusion
- • No exclusion criteria apply
Key Trial Info
Start Date :
January 26 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 27 2022
Estimated Enrollment :
153 Patients enrolled
Trial Details
Trial ID
NCT04725123
Start Date
January 26 2021
End Date
March 27 2022
Last Update
December 12 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
4th Department of Internal Medicine, ATTIKON University General Hospital
Athens, Greece, 12462